[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Editorial Board::
Executive Members::
Instruction to Authors::
Peer Review::
Articles Archive::
Indexing Databases::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 18, Issue 2 (6-2016) ::
J Gorgan Univ Med Sci 2016, 18(2): 97-101 Back to browse issues page
Evaluation of thyroid dysfunction and thyroid autoantibodies in patients with Vitiligo
Mohammadi R * 1, Aryaie M2 , Rohani Rasaf M3 , Mokhayeri Yaser4 , Dehghan M5
1- M.Sc in Epidemiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran. Ph.D Candidate in Epidemiology, Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran , rasool.mehr2002@gmail.com
2- Epidemiologist, Deputy of Research, Golestan University of Medical Science, Gorgan, Iran
3- Ph.D Candidate in Epidemiology, Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4- Ph.D Candidate in Epidemiology, Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran. M.Sc in Epidemiology, Department of Epidemiology, School of Public Health, Lorestan University of Medical Sc
5- Dermatologist, Gorgan, Iran
Abstract:   (14294 Views)

Background and Objective: Vitiligo is one of the most frequent skin disorders with a prevalence of 1-2% in different populations. Although many theories have been suggested for its pathogenesis, but the most popular hypotheses is the role of autoimmunity in Vitiligo. This study was done to evaluate the thyroid dysfunction and thyroid autoantibodies in patients with Vitiligo.

Methods: This case-control study was carried out on 45 patients with Vitiligo and 45 age- and sex-matched healthy individuals as control group. Age, gender, duration of the disease and type of Vitiligo were collected through a standard questionnaire. Thyroid autoantibodies including thyroglobulin antibody, anti- thyroglobulin and thyroid peroxidase antibody, and anti-TPO thyroid hormones Tetraiodothyronine (T4), Triiodothyronine (T3) and thyroid stimulating hormone (TSH) in Vitiligo patients and healthy volunteers were measeared.

Results: Serum level of T4 was significantly reduced in Vitiligo patient compared to controls (P<0.05). Serum level of T4 in 20% of Vitiligo patient and 2.2% of control cases was less the normal level. Anti-TPO in 14 (31.1%) of Vitiligo patient and 6 (13.3%) of controls were higher than normal range (<60 IU/m) (P<0.05). Serum level of anti- thyroglobulin was significantly higher in those with Vitiligo in compared to controls (P<0.05).

Conclusion: This study showed that the thyroid dysfunction particularly hypothyroidism and anti-TPO is more common in Vitiligo patients.

Keywords: Vitiligo, Thyroid dysfunction, Thyroid peroxidase antibody, Thyroglobulin antibody
Full-Text [PDF 178 kb] [English Abstract]   (16217 Downloads) |   |   Abstract (HTML)  (726 Views)  
Type of Study: Original Articles | Subject: Epidemiology
References
1. Sedighe M, Gholamhossein G. Thyroid dysfunction and thyroid antibodies in Iranian patients with vitiligo. Indian J Dermatol. 2008;53(1): 9-11. doi:10.4103/0019-5154.39733
2. Singh S, Singh U, Pandy SS. Thyroid dysfunction and anti-thyroid peroxidase antibody in patients with vitiligo. Int J Pharm Biol Arch. 2011; 2(3): 891-95.
3. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 2003 Jun; 16(3): 208-14.
4. Osman AM, Mirghani YA. Thyroid dysfunctions in sudanese patients with vitiligo. Sudan JMS. 2010; 5(1): 25-29.
5. Sandoval-Cruz M, García-Carrasco M, Sánchez-Porras R, Mendoza-Pinto C, Jiménez-Hernández M, Munguía-Realpozo P, et al. Immunopathogenesis of vitiligo. Autoimmun Rev. 2011 Oct; 10(12): 762-5. doi:10.1016/j.autrev.2011.02.004
6. Ziaul Amin Md, Hafizur Rahman M, Hassan P. Thyroid function in Bangladeshi patients with Vitiligo (Sheti). J Bio-Sci. 2008; 16:101-3. doi:10.3329/jbs.v16i0.3749
7. Iacovelli P, Sinagra JL, Vidolin AP, Marenda S, Capitanio B, Leone G, et al. Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology. 2005; 210(1): 26-30.
8. Rezaei N, Gavalas NG, Weetman AP, Kemp EH. Autoimmunity as an aetiological factor in vitiligo. J Eur Acad Dermatol Venereol. 2007 Aug; 21(7): 865-76.
9. Ongenae K, Van Geel N, Naeyaert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res. 2003 Apr; 16(2): 90-100.
10. Daneshpazhooh M, Mostofizadeh G M, Behjati J, Akhyani M, Robati RM. Anti-thyroid peroxidase antibody and vitiligo: a controlled study. BMC Dermatol. 2006 Mar; 6:3.
11. Uncu S, Yaylı S, Bahadır S, Okten A, Alpay K. Relevance of autoimmune thyroiditis in children and adolescents with vitiligo. Int J Dermatol. 2011 Feb; 50(2): 175-9. doi:10.1111/j.1365-4632.2010.04665.x
12. Zettinig G, Tanew A, Fischer G, Mayr W, Dudczak R, Weissel M. Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume? Clin Exp Immunol. 2003 Feb; 131(2): 347-54.
13. Altaf H, Shah IH, Ahmad QM. Evaluation of thyroid function and presence of antithyroid peroxidase antibodies in patients with vitiligo. Egyptian Dermatol Online J. 2010; 6(1): 3.
14. Zamanian A, Mobasher P, Ansar A, Manuchehri S, Jazi GA. Autoimmune thyroid disorders in patients with vitiligo. Journal of Skin and Stem Cell. 2014; 1(12): e22113. doi:10.17795/jssc22113
15. Majumder PP, Nordlund JJ, Nath SK. Pattern of familial aggregation of vitiligo. Arch Dermatol. 1993 Aug; 129(8): 994-8.
16. Fernandes NC, Campos MM. Childhood vitiligo and thyroid disease. An Bras Dermatol. 2009 Mar-Apr; 84(2): 200-2. [Article in English, Portuguese]
17. Kumar V, Shankar V, Chaudhary S, Bhatia KK, Mehta LK, Arora N, et al. Radio-active iodine uptake in vitiligo. J Dermatol. 1990 Jan; 17(1): 41-3.
18. Kasumagic-Halilovic E, Prohic A, Begovic B, Ovcina-Kurtovic N. Association between vitiligo and thyroid autoimmunity. Journal of Thyroid Research. 2011; (2011): Article ID 938257, 3 pages. http://dx.doi.org/10.4061/2011/938257
19. Zamanian A, Mobasher P, Ansar A, Manuchehri S, Ahmadi Jazi G. Autoimmune thyroid disorders in patients with vitiligo. J Skin Stem Cell. 2014 Oct; 1(2): e22113. doi:10.17795/jssc22113
20. Arýcan O, Koç K, Ersoy L. Clinical characteristics in 113 Turkish vitiligo patients. Acta Dermatovenerol Alp Pannonica Adriat. 2008 Sep; 17(3): 129-32.
21. Kmet J, Mahboubi E. Esophageal cancer in the Caspian littoral of Iran: initial studies. Science. 1972 Feb; 175(4024): 846-53.
22. Dave S, D'Souza M, Thappa DM, Reddy KS, Bobby ZB. High frequency of thyroid dysfunction in Indian patients with vitiligo. Indian Journal of Dermatology. 2003; 48(2): 68-72.
23. Daneshpazhooh M, Mostofizadeh G M, Behjati J, Akhyani M, Robati RM. Anti-thyroid peroxidase antibody and vitiligo: a controlled study. BMC Dermatology. 2006; 6:3. doi:10.1186/1471-5945-6-3
Send email to the article author


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammadi R, Aryaie M, Rohani Rasaf M, Mokhayeri Yaser, Dehghan M. Evaluation of thyroid dysfunction and thyroid autoantibodies in patients with Vitiligo. J Gorgan Univ Med Sci 2016; 18 (2) :97-101
URL: http://goums.ac.ir/journal/article-1-2768-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 18, Issue 2 (6-2016) Back to browse issues page
مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.04 seconds with 36 queries by YEKTAWEB 4660
Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)